Initial antithrombotic regimens after left atrial appendage closure did not significantly impact short-term clinical outcomes in a Japanese registry.
Do differences in antithrombotic regimens affect short-term clinical outcomes in patients with NVAF after percutaneous left atrial appendage closure?
In a Japanese real-world registry, variations in initial antithrombotic regimens after LAAC did not significantly impact short-term clinical outcomes.
Absolute Event Rate: 0% vs 0%
In a real-world registry from Japan, the initial antithrombotic regimen after LAAC was not commonly used, and differences in antithrombotic regimens did not significantly affect short-term clinical outcomes. (Transcatheter Modification of Left Atrial Appendage by Obliteration With Device in Patients With NVAF TERMINATOR; UMIN000044934.
Sugiyama et al. (Thu,) reported a other. Initial antithrombotic regimens after left atrial appendage closure did not significantly impact short-term clinical outcomes in a Japanese registry.